Sleep Apnea Devices Market - Global Forecast To 2032
商品番号 : SMB-5250
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 505 |
| 図表数 | 790 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本調査レポートは、睡眠時無呼吸症候群用装置市場を、製品別(治療機器(PAP装置、フェイシャルインターフェース、付属品、口腔内装置、その他治療機器)、診断機器(PSG装置、家庭用睡眠検査機器、酸素濃度計、アクチグラフィーシステム、睡眠スクリーニング機器))、エンドユーザー別(病院、在宅ケア施設、睡眠クリニック、外来診療センター、プライマリセンター、その他エンドユーザー)、年齢層別(小児、40歳未満、40~60歳、60歳以上)、性別別(男性患者、女性患者)、地域別(北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ)に分類しています。本レポートは、睡眠時無呼吸症候群用装置市場の成長に影響を与える主要な要因(促進要因、抑制要因、機会、課題など)に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、事業概要、ソリューション、主要戦略、買収、契約に関する洞察を提供しています。睡眠時無呼吸症候群治療機器市場における新製品・サービスの発売と最近の動向。本レポートでは、睡眠時無呼吸症候群用装置市場エコシステムにおける新興スタートアップ企業の競合分析を網羅しています。
The sleep apnea devices market is valued at an estimated USD 6.93 billion in 2025 and is projected to reach USD 11.61 billion by 2032 at a CAGR of 7.6% during the forecast period. Sleep apnea devices have become essential components in sleep medicine, utilized across avarious settings, including sleep laboratories, clinical environments, hospitals, and home care. As patients increasingly seek non-invasive therapeutic alternatives, the market for Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) machines is experiencing significant growth. Furthermore, emerging markets, particularly within the Asia Pacific region, present promising opportunities for expansion, driven by heightened awareness of sleep apnea and improved access to healthcare services.
睡眠時無呼吸症候群用装置市場は、2025年には推定69億3,000万米ドル規模に達し、予測期間中に年平均成長率(CAGR)7.6%で成長し、2032年には116億1,000万米ドルに達すると予測されています。睡眠時無呼吸症候群用装置は、睡眠検査室、臨床環境、病院、在宅ケアなど、様々な場面で利用されており、睡眠医療において不可欠な要素となっています。患者が非侵襲的な治療法を求める傾向が強まる中、持続的陽圧呼吸療法(CPAP)および二相性陽圧呼吸療法(BiPAP)機器の市場は著しい成長を遂げています。さらに、特にアジア太平洋地域における新興市場は、睡眠時無呼吸症候群に対する意識の高まりと医療サービスへのアクセス向上を背景に、有望な成長機会を提供しています。

“Therapeutic devices segment accounted for the highest growth rate in the sleep apnea devices market, by product, during the forecast period.”
The market is divided into two main segments: therapeutic devices and diagnostic devices. Among these, the therapeutic devices segment is projected to experience the most significant growth during the upcoming forecast period. This segment encompasses a variety of products, including positive airway pressure (PAP) devices, which are commonly used to treat conditions such as obstructive sleep apnea (OSA). Additionally, it includes facial interfaces, also known as masks, that are essential for ensuring the effective delivery of therapy, as well as various accessories that enhance the functionality and comfort of these devices. Oral appliances designed to manage sleep-disordered breathing conditions also fall under this segment, along with other innovative therapeutic tools. The anticipated growth of the therapeutic devices segment is primarily driven by an increase in diagnosis rates for sleep-related disorders. This rise in diagnoses is largely supported by the growing adoption of home sleep tests, which provide a more accessible and convenient means for patients to undergo evaluation. As more individuals become aware of their sleep issues through these diagnostic methods, the demand for effective therapeutic solutions is expected to surge, further propelling the market forward.
“The home care settings segment accounted for the highest growth rate in the sleep apnea devices market, by end user, during the forecast period.”
Among end users—hospitals, home care settings, sleep clinics, ambulatory care centers, primary centers, and others—the home care settings segment is projected to grow at the fastest rate. The growing trend towards home-based healthcare solutions is significantly transforming the landscape of medical diagnostics and treatment. In particular, the enhanced availability and accessibility of at-home sleep apnea testing is playing a crucial role in this shift. These innovations not only facilitate easier and more convenient testing for individuals suffering from sleep-related disorders but also lead to timely diagnoses. As a result, patients are able to receive appropriate treatment much faster than before. This trend is not only beneficial for patients but is also contributing to the overall expansion of the market by increasing awareness and encouraging more people to seek help for their sleep apnea concerns, ultimately fostering a healthier population.
“The Asia Pacific is expected to be the fastest-growing region in the sleep apnea devices market.”
The global market for human identification technologies is segmented into five key regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to experience the most significant growth rate throughout the forecast period. This trend can be attributed to the high volume of product launches and the regulatory approvals for innovative devices, which are enhancing market offerings and driving expansion in the area.
The break-up of the profile of primary participants in the sleep apnea devices market:
- By Company Type: Tier 1 – 5%, Tier 2 – 55%, and Tier 3 –40%
- By Designation: C-level – 37%, D-level – 48%, and Others – 15%
- By Region: North America – 56%, Europe – 20%, Asia Pacific – 17%, Rest of the World – 7%
The key players in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare Limited (New Zealand), Inspire Medical Systems, Inc. (US), SomnoMed (Australia), Openairway (Canada), Compumedics Limited (Australia), Löwenstein Medical SE & Co. KG (Germany), Drive DeVilbiss International (US), BMC (China), BRAEBON Medical Corporation (Canada), DynaFlex (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova PLC (UK), Invacare Holdings Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. Kg (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US).

Research Coverage:
This research report categorizes the sleep apnea devices market by product [Therapeutic devices (PAP devices, facial interfaces, accessories, oral appliances, other therapeutic devices), Diagnostic devices (PSG Devices, home sleep testing devices, oximeters, actigraphy systems, sleep screening devices)], by end user [hospitals, home care settings, sleep clinics, ambulatory care centers, primary centers, and other end users], by age group [pediatric, below 40 years, 40–60 years, and above 60 years], by gender [male patients and female patients], and by region [North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa]. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the sleep apnea devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches and recent developments associated with the sleep apnea devices market. This report covers a competitive analysis of upcoming startups in the sleep apnea devices market ecosystem.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall sleep apnea devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (large pool of undiagnosed obstructive sleep apnea patients, favorable reimbursement and financial aid for sleep apnea devices and therapies, growing awareness about effects of untreated sleep apnea among patients, rising use of oral appliances among patients with mild-to-moderate sleep apnea, increased investments and funding to develop advanced sleep apnea products), restraints (high cost of CPAP devices and minimal insurance access in emerging economies, complex referral pathways, long waiting periods, and delayed diagnosis, and use of alternative therapies and medications for sleep apnea), opportunities (rising demand for cost-effective home sleep apnea tests, increasing focus on telemedicine, mHealth, and artificial intelligence, high growth opportunities for sleep apnea manufacturers in emerging economies) and challenges (poor patient compliance with CPAP therapy) influencing the growth of the sleep apnea devices market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the sleep apnea devices market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the sleep apnea devices market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the sleep apnea devices market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare Limited (New Zealand).
Table of Contents
1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 45
1.3 STUDY SCOPE 46
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 46
1.3.2 INCLUSIONS & EXCLUSIONS 47
1.3.3 YEARS CONSIDERED 47
1.3.4 CURRENCY CONSIDERED 48
1.4 STAKEHOLDERS 48
1.5 SUMMARY OF CHANGES 48
2 RESEARCH METHODOLOGY 50
2.1 RESEARCH DATA 50
2.1.1 RESEARCH DESIGN 50
2.1.2 SECONDARY DATA 51
2.1.2.1 List of key secondary sources 51
2.1.2.2 Key data from secondary sources 52
2.1.2.3 Objectives of secondary research 52
2.1.3 PRIMARY DATA 53
2.1.3.1 List of key primaries 53
2.1.3.2 Objectives of primary research 53
2.1.3.3 Key industry insights 54
2.1.3.4 Key data from primary sources 54
2.1.3.5 Breakdown of primary interviews 55
2.2 MARKET SIZE ESTIMATION 56
2.2.1 BOTTOM-UP APPROACH 56
2.2.1.1 Company revenue estimation approach 57
2.2.1.2 Company presentations and primary interviews 57
2.2.1.3 Patient-based approach for sleep apnea oral appliances market sizing 57
2.2.1.4 Disease burden approach for PAP devices market sizing 59
2.2.1.5 Growth forecast 59
2.2.1.6 CAGR projections 59
2.2.2 TOP-DOWN APPROACH 60
2.3 DATA TRIANGULATION 61
2.4 MARKET SHARE ANALYSIS 62
2.5 STUDY ASSUMPTIONS 62
2.5.1 MARKET ASSUMPTIONS 62
2.5.2 GROWTH RATE ASSUMPTIONS 62
2.6 RESEARCH LIMITATIONS 63
2.7 RISK ANALYSIS 63
3 EXECUTIVE SUMMARY 64
4 PREMIUM INSIGHTS 68
4.1 SLEEP APNEA DEVICES MARKET OVERVIEW 68
4.2 SLEEP APNEA DEVICES MARKET, BY PRODUCT 69
4.3 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT AND COUNTRY 69
4.4 SLEEP APNEA DEVICES MARKET: REGIONAL MARKET SHARE 70
5 MARKET OVERVIEW 71
5.1 INTRODUCTION 71
5.2 MARKET DYNAMICS 71
5.2.1 DRIVERS 72
5.2.1.1 Large pool of undiagnosed obstructive sleep apnea (OSA) patients 72
5.2.1.2 Favorable reimbursement and financial aid for sleep apnea devices and therapies 73
5.2.1.3 Growing awareness about effects of untreated sleep apnea among patients 75
5.2.1.4 Rising use of oral appliances among patients with mild-to-moderate sleep apnea 76
5.2.1.5 Increased investments and funding to develop advanced sleep apnea products 77
5.2.2 RESTRAINTS 77
5.2.2.1 High cost of CPAP devices and minimal insurance access in emerging economies 77
5.2.2.2 Complex referral pathways, long waiting periods, and delayed diagnosis 78
5.2.2.3 Use of alternative therapies and medications for sleep apnea 78
5.2.3 OPPORTUNITIES 79
5.2.3.1 Rising demand for cost-effective home sleep apnea tests 79
5.2.3.2 Increasing focus on telemedicine, mHealth, and artificial intelligence 80
5.2.3.3 High growth opportunities for sleep apnea manufacturers in emerging economies 81
5.2.4 CHALLENGES 82
5.2.4.1 Poor patient compliance with CPAP therapy 82
5.3 INDUSTRY TRENDS 82
5.3.1 RISING ADOPTION OF ADVANCED SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC TECHNOLOGIES 82
5.4 PRICING ANALYSIS 83
5.4.1 AVERAGE SELLING PRICE TREND OF SLEEP APNEA DEVICES, BY REGION, 2023–2025 83
5.4.2 AVERAGE SELLING PRICE TREND OF SLEEP APNEA DEVICES,
BY PRODUCT TYPE, 2023–2025 84
5.4.3 AVERAGE SELLING PRICE TREND OF SLEEP APNEA ORAL APPLIANCES,
BY KEY PLAYER, 2023−2025 85
5.5 VALUE CHAIN ANALYSIS 86
5.6 SUPPLY CHAIN ANALYSIS 87
5.7 UNMET NEEDS/END-USER EXPECTATIONS 88
5.8 PORTER’S FIVE FORCES ANALYSIS 88
5.8.1 THREAT OF NEW ENTRANTS 89
5.8.2 THREAT OF SUBSTITUTES 90
5.8.3 BARGAINING POWER OF SUPPLIERS 90
5.8.4 BARGAINING POWER OF BUYERS 90
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 91
5.9 KEY STAKEHOLDERS & BUYING CRITERIA 91
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 91
5.9.2 KEY BUYING CRITERIA 92
5.10 ECOSYSTEM ANALYSIS 93
5.10.1 ROLE IN ECOSYSTEM 93
5.11 REGULATORY ANALYSIS 94
5.11.1 REGULATORY FRAMEWORK 94
5.11.1.1 North America 94
5.11.1.1.1 US 94
5.11.1.1.1.1 Reimbursement scenario in US 95
5.11.1.1.2 Canada 96
5.11.1.2 Europe 96
5.11.1.3 Asia Pacific 97
5.11.1.3.1 Japan 97
5.11.1.3.2 China 97
5.11.1.3.3 India 98
5.11.1.3.4 Australia 99
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
5.12 PATENT ANALYSIS 102
5.12.1 INSIGHTS ON PATENT PUBLICATION TRENDS (TOP APPLICANTS/ JURISDICTION) 103
5.13 ADJACENT MARKET ANALYSIS 103
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 104
5.15 KEY CONFERENCES & EVENTS, 2025−2026 105
5.16 TECHNOLOGY ANALYSIS 106
5.16.1 KEY TECHNOLOGIES 106
5.16.1.1 PAP devices 106
5.16.2 ADJACENT TECHNOLOGIES 107
5.16.2.1 Oral appliances 107
5.16.3 COMPLEMENTARY TECHNOLOGIES 107
5.16.3.1 Daytime-Nighttime appliances 107
5.17 TRADE ANALYSIS 108
5.17.1 IMPORT DATA FOR HS CODE 901849, 2020–2024 108
5.17.2 EXPORT DATA FOR HS CODE 901849, 2020–2024 108
5.18 INVESTMENT & FUNDING SCENARIO 109
5.19 IMPACT OF AI/GEN AI ON SLEEP APNEA DEVICES MARKET 109
5.19.1 MARKET POTENTIAL FOR SLEEP APNEA ORAL APPLIANCES 110
5.19.2 FUTURE OF GENERATIVE AI IN SLEEP APNEA DEVICES MARKET 111
5.20 IMPACT OF 2025 US TARIFF ON SLEEP APNEA DEVICES MARKET 112
5.20.1 INTRODUCTION 112
5.20.2 KEY TARIFF RATES 112
5.20.3 PRICE IMPACT ANALYSIS 113
5.20.4 IMPACT ON COUNTRY/REGION 113
5.20.4.1 North America 113
5.20.4.1.1 US 113
5.20.4.2 Europe 114
5.20.4.2.1 Germany 114
5.20.4.2.2 UK and France 114
5.20.4.3 Asia Pacific 114
5.20.4.3.1 China 114
5.20.4.3.2 Japan 114
5.20.4.3.3 India 114
5.20.5 IMPACT ON END-USE INDUSTRIES 115
5.20.5.1 Hospitals 115
5.20.5.2 Sleep clinics 115
5.20.5.3 Ambulatory surgery centers 115
5.20.5.4 Primary centres 115
5.20.5.5 Home care centers 115
5.20.5.6 Urgent care centers 115
6 SLEEP APNEA DEVICES MARKET, BY PRODUCT 116
6.1 INTRODUCTION 117
6.2 THERAPEUTIC DEVICES 117
6.2.1 PAP DEVICES 120
6.2.1.1 CPAP devices 123
6.2.1.1.1 Technological advancements and better reimbursement facilities to boost segment growth 123
6.2.1.2 APAP devices 127
6.2.1.2.1 Better customization facility to augment market growth 127
6.2.1.3 BPAP devices 130
6.2.1.3.1 Increased product recalls and more complex operations to lower adoption 130
6.2.2 FACIAL INTERFACES 134
6.2.2.1 Masks 137
6.2.2.1.1 Full-face masks 142
6.2.2.1.1.1 Full-face masks to be most effective for mouth breathers 142
6.2.2.1.2 Nasal pillow masks 146
6.2.2.1.2.1 Greater patient compliance to support segment growth 146
6.2.2.1.3 Nasal masks 149
6.2.2.1.3.1 Ease of use and reduced claustrophobic nature to aid adoption 149
6.2.2.2 Cushions 152
6.2.2.2.1 Better insurance coverage to propel segment growth 152
6.2.3 ACCESSORIES 155
6.2.3.1 Humidifier accessories 159
6.2.3.1.1 Humidifiers to open airways, decrease congestion, and encourage clearer breathing 159
6.2.3.2 Power accessories 163
6.2.3.2.1 Power accessories to manage uninterrupted sleep apnea therapy without power supply 163
6.2.3.3 Transportation accessories 166
6.2.3.3.1 Rising need to carry sleep apnea devices while traveling to spur segment growth 166
6.2.3.4 Communication accessories 169
6.2.3.4.1 Need for easy teleconsultations for remote patients to fuel segment growth 169
6.2.3.5 Chin restraints 173
6.2.3.5.1 Growing need for obstructive sleep apnea management with therapeutic devices to drive segment 173
6.2.3.6 Other accessories 175
6.2.4 ORAL APPLIANCES 178
6.2.4.1 Mandibular advancement devices 182
6.2.4.1.1 Low-cost devices with maximum anterior tongue space to drive segment 182
6.2.4.2 Tongue-retaining devices 186
6.2.4.2.1 Need for more affordable and comfortable treatment options to support segment growth 186
6.2.4.3 Daytime-Nighttime appliances 189
6.2.4.3.1 Increased focus on comfortable, non-surgical, and low-risk treatments to drive segment 189
6.2.5 OTHER THERAPEUTIC DEVICES 190
6.3 DIAGNOSTIC DEVICES 194
6.3.1 PSG DEVICES 197
6.3.1.1 Ambulatory PSG devices 201
6.3.1.1.1 Need for cost-effective and technologically advanced ambulatory devices to propel segment growth 201
6.3.1.2 Clinical PSG devices 204
6.3.1.2.1 Labor-intensive and expensive procedures to limit segment 204
6.3.2 HOME SLEEP TESTING DEVICES 207
6.3.2.1 Increased need for cost-effective and comfortable home sleep testing devices to augment segment growth 207
6.3.3 OXIMETERS 210
6.3.3.1 Fingertip oximeters 214
6.3.3.1.1 Lack of precise reading due to injury or slow blood flow to limit segment growth 214
6.3.3.2 Handheld oximeters 218
6.3.3.2.1 Easy customizations and ease of distant reading to spur segment growth 218
6.3.3.3 Wrist-worn oximeters 221
6.3.3.3.1 Small size and easy portability for overnight monitoring to propel segment growth 221
6.3.3.4 Tabletop oximeters 225
6.3.3.4.1 Higher cost and fewer applications for personal use to decrease market share 225
6.3.4 ACTIGRAPHY SYSTEMS 228
6.3.4.1 Increased research on sleep and wake patterns to drive market 228
6.3.5 SLEEP SCREENING DEVICES 232
6.3.5.1 Increasing preference for home-based sleep apnea testing to propel market growth 232
7 SLEEP APNEA DEVICES MARKET, BY AGE GROUP 236
7.1 INTRODUCTION 237
7.2 PEDIATRIC 237
7.2.1 PREVALENCE OF OBESITY, CRANIOFACIAL ABNORMALITIES, AND NEUROMUSCULAR DISORDERS TO PROPEL MARKET GROWTH 237
7.3 BELOW 40 YEARS 241
7.3.1 LOWER PREVALENCE OF SLEEP APNEA IN YOUNGER AGE GROUPS TO LIMIT MARKET GROWTH 241
7.4 40–60 YEARS 244
7.4.1 UNDERDIAGNOSIS AND UNHEALTHY LIFESTYLE TO AID MARKET GROWTH 244
7.5 ABOVE 60 YEARS 247
7.5.1 HIGH OCCURRENCE OF CHRONIC MEDICAL CONDITIONS AND SLEEP-RELATED DISORDERS TO DRIVE MARKET 247
8 SLEEP APNEA DEVICES MARKET, BY GENDER 251
8.1 INTRODUCTION 252
8.2 MALE PATIENTS 253
8.2.1 HIGHER PREVALENCE OF SLEEP-RELATED BREATHING DISORDERS TO BOOST MARKET GROWTH 253
8.3 FEMALE PATIENTS 255
8.3.1 IMPROVED RECOGNITION AND DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA TO AID MARKET GROWTH 255
9 SLEEP APNEA DEVICES MARKET, BY END USER 259
9.1 INTRODUCTION 260
9.2 HOSPITALS 260
9.2.1 INCREASED POPULARITY PRIVATE HOSPITALS WITH ADVANCED INFRASTRUCTURE TO AUGMENT MARKET GROWTH 260
9.3 HOME CARE SETTINGS 264
9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET GROWTH 264
9.4 SLEEP CLINICS 268
9.4.1 INCREASING NEED FOR ADVANCED DIAGNOSTIC DEVICES AND SLEEP SPECIALISTS TO SUPPORT MARKET GROWTH 268
9.5 AMBULATORY CARE CENTERS 272
9.5.1 RISING ADOPTION OF PORTABLE DIAGNOSTIC DEVICES TO IMPROVE DIAGNOSIS AND TREATMENT IN OUTPATIENT SETTINGS 272
9.6 PRIMARY CENTERS 276
9.6.1 PRIMARY CENTERS TO CONDUCT FOLLOW-UP CARE AND COORDINATE PATIENTS WITH SLEEP SPECIALISTS 276
9.7 OTHER END USERS 279
10 SLEEP APNEA DEVICES MARKET, BY REGION 283
10.1 INTRODUCTION 284
10.2 NORTH AMERICA 284
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 284
10.2.2 US 292
10.2.2.1 US to dominate North American sleep apnea devices market during forecast period 292
10.2.3 CANADA 298
10.2.3.1 Increasing number of research grants and health programs to propel market growth 298
10.3 EUROPE 305
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 305
10.3.2 GERMANY 311
10.3.2.1 High prevalence of obstructive sleep apnea and increased geriatric population to fuel market growth 311
10.3.3 UK 317
10.3.3.1 Rising awareness among patients about sleep apnea to support market growth 317
10.3.4 FRANCE 323
10.3.4.1 Rising geriatric population and obesity rates to favor market growth 323
10.3.5 ITALY 328
10.3.5.1 Favorable initiatives by dental associations and increased awareness about obstructive sleep apnea to drive market 328
10.3.6 SPAIN 333
10.3.6.1 Social awareness initiatives by regional organizations regarding obstructive sleep apnea to aid market growth 333
10.3.7 REST OF EUROPE 338
10.4 ASIA PACIFIC 345
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 345
10.4.2 CHINA 352
10.4.2.1 Growing prevalence of obesity and diabetes in adults to propel market growth 352
10.4.3 JAPAN 357
10.4.3.1 Favorable reimbursement scenario and high demand for cloud-connected sleep apnea therapeutic devices to aid market growth 357
10.4.4 AUSTRALIA 362
10.4.4.1 Increasing number of sleep clinics to augment market growth 362
10.4.5 REST OF ASIA PACIFIC 367
10.5 LATIN AMERICA 374
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 374
10.5.2 BRAZIL 381
10.5.2.1 Favorable reimbursement policies and increased awareness about sleeping disorders to drive market 381
10.5.3 MEXICO 386
10.5.3.1 Poor healthcare infrastructure and lack of public health initiatives to limit market growth 386
10.5.4 REST OF LATIN AMERICA 391
10.6 MIDDLE EAST & AFRICA 398
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 398
10.6.2 GCC COUNTRIES 406
10.6.2.1 Kingdom of Saudi Arabia 412
10.6.2.1.1 High obesity rates among women to propel market growth 412
10.6.2.2 UAE 418
10.6.2.2.1 Greater focus on early diagnosis and healthcare infrastructural advancements to drive market 418
10.6.2.3 Rest of GCC countries 424
10.6.3 REST OF MIDDLE EAST & AFRICA 431
11 COMPETITIVE LANDSCAPE 438
11.1 INTRODUCTION 438
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 438
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA DEVICES MARKET 438
11.3 REVENUE ANALYSIS, 2020–2024 440
11.4 MARKET SHARE ANALYSIS, 2024 441
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 442
11.5.1 STARS 442
11.5.2 EMERGING LEADERS 443
11.5.3 PERVASIVE PLAYERS 443
11.5.4 PARTICIPANTS 443
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 444
11.5.5.1 Company footprint 444
11.5.5.2 Region footprint 444
11.5.5.3 Product footprint 445
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 446
11.6.1 PROGRESSIVE COMPANIES 446
11.6.2 RESPONSIVE COMPANIES 446
11.6.3 DYNAMIC COMPANIES 446
11.6.4 STARTING BLOCKS 446
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 447
11.6.5.1 Detailed list of key startups/SMEs 447
11.6.5.2 Competitive benchmarking of key startups/SMEs 448
11.7 COMPANY VALUATION & FINANCIAL METRICS 449
11.7.1 FINANCIAL METRICS 449
11.7.2 COMPANY VALUATION 449
11.8 BRAND/PRODUCT COMPARISON 450
11.9 COMPETITIVE SCENARIO 450
11.9.1 PRODUCT LAUNCHES & APPROVALS 450
11.9.2 DEALS 451
11.9.3 EXPANSIONS 452
11.9.4 OTHER DEVELOPMENTS 452
12 COMPANY PROFILES 453
12.1 KEY PLAYERS 453
12.1.1 RESMED 453
12.1.1.1 Business overview 453
12.1.1.2 Products offered 454
12.1.1.3 Recent developments 457
12.1.1.3.1 Product launches 457
12.1.1.3.2 Deals 457
12.1.1.3.3 Expansions 458
12.1.1.4 MnM view 458
12.1.1.4.1 Key strengths 458
12.1.1.4.2 Strategic choices 458
12.1.1.4.3 Weaknesses & competitive threats 458
12.1.2 KONINKLIJKE PHILIPS N.V. 459
12.1.2.1 Business overview 459
12.1.2.2 Products offered 460
12.1.2.3 MnM view 462
12.1.2.3.1 Key strengths 462
12.1.2.3.2 Strategic choices 462
12.1.2.3.3 Weaknesses & competitive threats 463
12.1.3 FISHER & PAYKEL HEALTHCARE LIMITED 464
12.1.3.1 Business overview 464
12.1.3.2 Products offered 465
12.1.3.3 Recent developments 467
12.1.3.3.1 Product launches 467
12.1.3.4 MnM view 468
12.1.3.4.1 Key strengths 468
12.1.3.4.2 Strategic choices 468
12.1.3.4.3 Weaknesses & competitive threats 468
12.1.4 INSPIRE MEDICAL SYSTEMS, INC. 469
12.1.4.1 Business overview 469
12.1.4.2 Products offered 470
12.1.4.3 MnM view 470
12.1.4.3.1 Key strengths 470
12.1.4.3.2 Strategic choices 470
12.1.4.3.3 Weaknesses & competitive threats 470
12.1.5 SOMNOMED 471
12.1.5.1 Business overview 471
12.1.5.2 Products offered 472
12.1.5.3 MnM view 472
12.1.5.3.1 Key strengths 472
12.1.5.3.2 Strategic choices 472
12.1.5.3.3 Weaknesses & competitive threats 472
12.1.6 OPENAIRWAY 473
12.1.6.1 Business overview 473
12.1.6.2 Products offered 473
12.1.7 COMPUMEDICS LIMITED 474
12.1.7.1 Business overview 474
12.1.7.2 Products offered 475
12.1.7.3 Recent developments 476
12.1.7.3.1 Product approvals 476
12.1.8 LÖWENSTEIN MEDICAL SE & CO. KG 477
12.1.8.1 Business overview 477
12.1.8.2 Products offered 477
12.1.9 DRIVE DEVILBISS INTERNATIONAL 479
12.1.9.1 Business overview 479
12.1.9.2 Products offered 479
12.1.10 BMC 480
12.1.10.1 Business overview 480
12.1.10.2 Products offered 480
12.1.11 BRAEBON MEDICAL CORPORATION 482
12.1.11.1 Business overview 482
12.1.11.2 Products offered 482
12.1.12 DYNAFLEX 483
12.1.12.1 Business overview 483
12.1.12.2 Products offered 483
12.1.12.3 Recent developments 483
12.1.12.3.1 Deals 483
12.1.13 PANTHERA DENTAL 484
12.1.13.1 Business overview 484
12.1.13.2 Products offered 484
12.1.13.3 Recent developments 484
12.1.13.3.1 Deals 484
12.1.13.3.2 Other developments 485
12.1.14 MYERSON LLC 486
12.1.14.1 Business overview 486
12.1.14.2 Products offered 486
12.1.15 PROSOMNUS SLEEP TECHNOLOGIES 487
12.1.15.1 Business overview 487
12.1.15.2 Products offered 488
12.1.15.3 Recent developments 488
12.1.15.3.1 Deals 488
12.2 OTHER PLAYERS 489
12.2.1 NIDEK MEDICAL INDIA 489
12.2.2 TOMED GMBH 489
12.2.3 LIVANOVA PLC 490
12.2.4 INVACARE HOLDINGS CORPORATION 490
12.2.5 MPOWRX HEALTH & WELLNESS PRODUCTS INC. 491
12.2.6 NIHON KOHDEN CORPORATION 492
12.2.7 SICAT GMBH & CO. KG 493
12.2.8 VIVOS THERAPEUTICS, INC. 494
12.2.9 AIRWAY MANAGEMENT 495
12.2.10 APNEA SCIENCES 496
13 APPENDIX 497
13.1 DISCUSSION GUIDE 497
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 501
13.3 CUSTOMIZATION OPTIONS 503
13.4 RELATED REPORTS 503
13.5 AUTHOR DETAILS 504
LIST OF TABLES
TABLE 1 SLEEP APNEA DEVICES MARKET: INCLUSIONS & EXCLUSIONS 47
TABLE 2 SLEEP APNEA DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES 54
TABLE 3 SLEEP APNEA DEVICES MARKET: RISK ANALYSIS 63
TABLE 4 ESTIMATED PREVALENCE OF SLEEP APNEA, 2022–2024 (MILLION) 72
TABLE 5 REIMBURSEMENT CODES AND COSTS OF KEY SLEEP APNEA DEVICES BY RESMED 74
TABLE 6 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL LTD. 75
TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF
UNTREATED SLEEP APNEA 75
TABLE 8 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING
MILD-TO-MODERATE SLEEP APNEA 76
TABLE 9 AVERAGE SELLING PRICE TREND OF SLEEP APNEA DEVICES, BY REGION,
2023–2025 83
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY SLEEP APNEA DEVICES, BY PRODUCT TYPE, 2023–2025 85
TABLE 11 AVERAGE SELLING PRICE TREND OF SLEEP APNEA ORAL APPLIANCES,
BY KEY PLAYER, 2023−2025 85
TABLE 12 SLEEP APNEA DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 88
TABLE 13 SLEEP APNEA DEVICES MARKET: PORTER’S FIVE FORCES 88
TABLE 14 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 92
TABLE 15 KEY BUYING CRITERIA FOR MAJOR END USERS 92
TABLE 16 SLEEP APNEA DEVICES MARKET: ROLE IN ECOSYSTEM 93
TABLE 17 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 95
TABLE 18 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 96
TABLE 19 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 97
TABLE 20 CHINA: CLASSIFICATION OF MEDICAL DEVICES 98
TABLE 21 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 22 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 23 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 24 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 25 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 26 LIST OF ADDITIONAL REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 27 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026 105
TABLE 28 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2020–2024 (USD MILLION) 108
TABLE 29 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2020–2024 (USD MILLION) 108
TABLE 30 US ADJUSTED RECIPROCAL TARIFF RATES 112
TABLE 31 SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 117
TABLE 32 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 117
TABLE 33 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2023–2032 (USD MILLION) 118
TABLE 34 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 118
TABLE 35 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 119
TABLE 36 ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 119
TABLE 37 LATIN AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 120
TABLE 38 MIDDLE EAST & AFRICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET,
BY COUNTRY, 2023–2032 (USD MILLION) 120
TABLE 39 PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 121
TABLE 40 PAP DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 121
TABLE 41 NORTH AMERICA: PAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 121
TABLE 42 EUROPE: PAP DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 122
TABLE 43 ASIA PACIFIC: PAP DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 122
TABLE 44 LATIN AMERICA: PAP DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 123
TABLE 45 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 123
TABLE 46 CPAP DEVICES OFFERED BY KEY PLAYERS 124
TABLE 47 CPAP DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 125
TABLE 48 NORTH AMERICA: CPAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 125
TABLE 49 EUROPE: CPAP DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 126
TABLE 50 ASIA PACIFIC: CPAP DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 126
TABLE 51 LATIN AMERICA: CPAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 127
TABLE 52 MIDDLE EAST & AFRICA: CPAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 127
TABLE 53 APAP DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 128
TABLE 54 NORTH AMERICA: APAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 128
TABLE 55 EUROPE: APAP DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 129
TABLE 56 ASIA PACIFIC: APAP DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 129
TABLE 57 LATIN AMERICA: APAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 130
TABLE 58 MIDDLE EAST & AFRICA: APAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 130
TABLE 59 BPAP DEVICES OFFERED BY KEY PLAYERS 131
TABLE 60 BPAP DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 132
TABLE 61 NORTH AMERICA: BPAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 132
TABLE 62 EUROPE: BPAP DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 133
TABLE 63 ASIA PACIFIC: BPAP DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 133
TABLE 64 LATIN AMERICA: BPAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 134
TABLE 65 MIDDLE EAST & AFRICA: BPAP DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 134
TABLE 66 FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 135
TABLE 67 FACIAL INTERFACES MARKET, BY REGION, 2023–2032 (USD MILLION) 135
TABLE 68 NORTH AMERICA: FACIAL INTERFACES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 135
TABLE 69 EUROPE: FACIAL INTERFACES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 136
TABLE 70 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 136
TABLE 71 LATIN AMERICA: FACIAL INTERFACES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 137
TABLE 72 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 137
TABLE 73 MASKS OFFERED BY KEY PLAYERS 138
TABLE 74 MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 139
TABLE 75 MASKS MARKET, BY REGION, 2023–2032 (USD MILLION) 140
TABLE 76 NORTH AMERICA: MASKS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 140
TABLE 77 EUROPE: MASKS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 141
TABLE 78 ASIA PACIFIC: MASKS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 141
TABLE 79 LATIN AMERICA: MASKS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 142
TABLE 80 MIDDLE EAST & AFRICA: MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 142
TABLE 81 FULL-FACE MASKS OFFERED BY KEY PLAYERS 143
TABLE 82 FULL-FACE MASKS MARKET, BY REGION, 2023–2032 (USD MILLION) 143
TABLE 83 NORTH AMERICA: FULL-FACE MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 144
TABLE 84 EUROPE: FULL-FACE MASKS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 144
TABLE 85 ASIA PACIFIC: FULL-FACE MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 145
TABLE 86 LATIN AMERICA: FULL-FACE MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 145
TABLE 87 MIDDLE EAST & AFRICA: FULL-FACE MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 146
TABLE 88 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS 147
TABLE 89 NASAL PILLOW MASKS MARKET, BY REGION, 2023–2032 (USD MILLION) 147
TABLE 90 NORTH AMERICA: NASAL PILLOW MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 147
TABLE 91 EUROPE: NASAL PILLOW MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 148
TABLE 92 ASIA PACIFIC: NASAL PILLOW MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 148
TABLE 93 LATIN AMERICA: NASAL PILLOW MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 149
TABLE 94 MIDDLE EAST & AFRICA: NASAL PILLOW MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 149
TABLE 95 NASAL MASKS MARKET, BY REGION, 2023–2032 (USD MILLION) 150
TABLE 96 NORTH AMERICA: NASAL MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 150
TABLE 97 EUROPE: NASAL MASKS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 151
TABLE 98 ASIA PACIFIC: NASAL MASKS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 151
TABLE 99 LATIN AMERICA: NASAL MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 152
TABLE 100 MIDDLE EAST & AFRICA: NASAL MASKS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 152
TABLE 101 CUSHIONS OFFERED BY KEY PLAYERS 153
TABLE 102 CUSHIONS MARKET, BY REGION, 2023–2032 (USD MILLION) 153
TABLE 103 NORTH AMERICA: CUSHIONS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 153
TABLE 104 EUROPE: CUSHIONS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 154
TABLE 105 ASIA PACIFIC: CUSHIONS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 154
TABLE 106 LATIN AMERICA: CUSHIONS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 155
TABLE 107 MIDDLE EAST & AFRICA: CUSHIONS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 155
TABLE 108 ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 156
TABLE 109 ACCESSORIES MARKET, BY REGION, 2023–2032 (USD MILLION) 156
TABLE 110 NORTH AMERICA: ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 157
TABLE 111 EUROPE: ACCESSORIES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 157
TABLE 112 ASIA PACIFIC: ACCESSORIES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 158
TABLE 113 LATIN AMERICA: ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 158
TABLE 114 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 159
TABLE 115 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2023–2032 (USD MILLION) 160
TABLE 116 NORTH AMERICA: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 160
TABLE 117 EUROPE: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 161
TABLE 118 ASIA PACIFIC: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 161
TABLE 119 LATIN AMERICA: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 162
TABLE 120 MIDDLE EAST & AFRICA: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 162
TABLE 121 POWER ACCESSORIES MARKET, BY REGION, 2023–2032 (USD MILLION) 163
TABLE 122 NORTH AMERICA: POWER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 163
TABLE 123 EUROPE: POWER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 164
TABLE 124 ASIA PACIFIC: POWER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 164
TABLE 125 LATIN AMERICA: POWER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 165
TABLE 126 MIDDLE EAST & AFRICA: POWER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 165
TABLE 127 TRANSPORTATION ACCESSORIES MARKET, BY REGION,
2023–2032 (USD MILLION) 166
TABLE 128 NORTH AMERICA: TRANSPORTATION ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 167
TABLE 129 EUROPE: TRANSPORTATION ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 167
TABLE 130 ASIA PACIFIC: TRANSPORTATION ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 168
TABLE 131 LATIN AMERICA: TRANSPORTATION ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 168
TABLE 132 MIDDLE EAST & AFRICA: TRANSPORTATION ACCESSORIES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 169
TABLE 133 COMMUNICATION ACCESSORIES MARKET, BY REGION,
2023–2032 (USD MILLION) 170
TABLE 134 NORTH AMERICA: COMMUNICATION ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 170
TABLE 135 EUROPE: COMMUNICATION ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 171
TABLE 136 ASIA PACIFIC: COMMUNICATION ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 171
TABLE 137 LATIN AMERICA: COMMUNICATION ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 172
TABLE 138 MIDDLE EAST & AFRICA: COMMUNICATION ACCESSORIES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 172
TABLE 139 CHIN RESTRAINTS MARKET, BY REGION, 2023–2032 (USD MILLION) 173
TABLE 140 NORTH AMERICA: CHIN RESTRAINTS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 173
TABLE 141 EUROPE: CHIN RESTRAINTS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 174
TABLE 142 ASIA PACIFIC: CHIN RESTRAINTS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 174
TABLE 143 LATIN AMERICA: CHIN RESTRAINTS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 175
TABLE 144 MIDDLE EAST & AFRICA: CHIN RESTRAINTS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 175
TABLE 145 OTHER ACCESSORIES MARKET, BY REGION, 2023–2032 (USD MILLION) 176
TABLE 146 NORTH AMERICA: OTHER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 176
TABLE 147 EUROPE: OTHER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 177
TABLE 148 ASIA PACIFIC: OTHER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 177
TABLE 149 LATIN AMERICA: OTHER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 178
TABLE 150 MIDDLE EAST & AFRICA: OTHER ACCESSORIES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 178
TABLE 151 ORAL APPLIANCES OFFERED BY KEY PLAYERS 179
TABLE 152 ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 180
TABLE 153 ORAL APPLIANCES MARKET, BY REGION, 2023–2032 (USD MILLION) 180
TABLE 154 NORTH AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 180
TABLE 155 EUROPE: ORAL APPLIANCES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 181
TABLE 156 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 181
TABLE 157 LATIN AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 182
TABLE 158 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 182
TABLE 159 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION,
2023–2032 (USD MILLION) 183
TABLE 160 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 183
TABLE 161 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 184
TABLE 162 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 184
TABLE 163 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 185
TABLE 164 MIDDLE EAST & AFRICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2023–2032 (USD MILLION) 185
TABLE 165 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 186
TABLE 166 NORTH AMERICA: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 187
TABLE 167 EUROPE: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 187
TABLE 168 ASIA PACIFIC: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 188
TABLE 169 LATIN AMERICA: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 188
TABLE 170 MIDDLE EAST & AFRICA: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 189
TABLE 171 DAYTIME-NIGHTTIME APPLIANCES MARKET, BY REGION,
2023–2032 (USD MILLION) 189
TABLE 172 OTHER THERAPEUTIC DEVICES OFFERED BY KEY PLAYERS 190
TABLE 173 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 191
TABLE 174 NORTH AMERICA: OTHER THERAPEUTIC DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 191
TABLE 175 EUROPE: OTHER THERAPEUTIC DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 192
TABLE 176 ASIA PACIFIC: OTHER THERAPEUTIC DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 192
TABLE 177 LATIN AMERICA: OTHER THERAPEUTIC DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 193
TABLE 178 MIDDLE EAST & AFRICA: OTHER THERAPEUTIC DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 193
TABLE 179 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 194
TABLE 180 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION,
2023–2032 (USD MILLION) 194
TABLE 181 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 195
TABLE 182 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 195
TABLE 183 ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 196
TABLE 184 LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 196
TABLE 185 MIDDLE EAST & AFRICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET,
BY COUNTRY, 2023–2032 (USD MILLION) 197
TABLE 186 PSG DEVICES OFFERED BY KEY PLAYERS 197
TABLE 187 PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 198
TABLE 188 PSG DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 198
TABLE 189 NORTH AMERICA: PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 198
TABLE 190 EUROPE: PSG DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 199
TABLE 191 ASIA PACIFIC: PSG DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 199
TABLE 192 LATIN AMERICA: PSG DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 200
TABLE 193 MIDDLE EAST & AFRICA: PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 200
TABLE 194 AMBULATORY PSG DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 201
TABLE 195 NORTH AMERICA: AMBULATORY PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 202
TABLE 196 EUROPE: AMBULATORY PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 202
TABLE 197 ASIA PACIFIC: AMBULATORY PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 203
TABLE 198 LATIN AMERICA: AMBULATORY PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 203
TABLE 199 MIDDLE EAST & AFRICA: AMBULATORY PSG DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 204
TABLE 200 CLINICAL PSG DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 204
TABLE 201 NORTH AMERICA: CLINICAL PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 205
TABLE 202 EUROPE: CLINICAL PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 205
TABLE 203 ASIA PACIFIC: CLINICAL PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 206
TABLE 204 LATIN AMERICA: CLINICAL PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 206
TABLE 205 MIDDLE EAST & AFRICA: CLINICAL PSG DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 207
TABLE 206 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 208
TABLE 207 NORTH AMERICA: HOME SLEEP TESTING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 208
TABLE 208 EUROPE: HOME SLEEP TESTING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 209
TABLE 209 ASIA PACIFIC: HOME SLEEP TESTING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 209
TABLE 210 LATIN AMERICA: HOME SLEEP TESTING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 210
TABLE 211 MIDDLE EAST & AFRICA: HOME SLEEP TESTING DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 210
TABLE 212 OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 211
TABLE 213 OXIMETERS MARKET, BY REGION, 2023–2032 (USD MILLION) 211
TABLE 214 NORTH AMERICA: OXIMETERS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 212
TABLE 215 EUROPE: OXIMETERS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 212
TABLE 216 ASIA PACIFIC: OXIMETERS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 213
TABLE 217 LATIN AMERICA: OXIMETERS MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 213
TABLE 218 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 214
TABLE 219 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS 214
TABLE 220 FINGERTIP OXIMETERS MARKET, BY REGION, 2023–2032 (USD MILLION) 215
TABLE 221 NORTH AMERICA: FINGERTIP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 215
TABLE 222 EUROPE: FINGERTIP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 216
TABLE 223 ASIA PACIFIC: FINGERTIP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 216
TABLE 224 LATIN AMERICA: FINGERTIP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 217
TABLE 225 MIDDLE EAST & AFRICA: FINGERTIP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 217
TABLE 226 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS 218
TABLE 227 HANDHELD OXIMETERS MARKET, BY REGION, 2023–2032 (USD MILLION) 218
TABLE 228 NORTH AMERICA: HANDHELD OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 219
TABLE 229 EUROPE: HANDHELD OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 219
TABLE 230 ASIA PACIFIC: HANDHELD OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 220
TABLE 231 LATIN AMERICA: HANDHELD OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 220
TABLE 232 MIDDLE EAST & AFRICA: HANDHELD OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 221
TABLE 233 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS 221
TABLE 234 WRIST-WORN OXIMETERS MARKET, BY REGION, 2023–2032 (USD MILLION) 222
TABLE 235 NORTH AMERICA: WRIST-WORN OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 222
TABLE 236 EUROPE: WRIST-WORN OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 223
TABLE 237 ASIA PACIFIC: WRIST-WORN OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 223
TABLE 238 LATIN AMERICA: WRIST-WORN OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 224
TABLE 239 MIDDLE EAST & AFRICA: WRIST-WORN OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 224
TABLE 240 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS 225
TABLE 241 TABLETOP OXIMETERS MARKET, BY REGION, 2023–2032 (USD MILLION) 225
TABLE 242 NORTH AMERICA: TABLETOP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 226
TABLE 243 EUROPE: TABLETOP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 226
TABLE 244 ASIA PACIFIC: TABLETOP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 227
TABLE 245 LATIN AMERICA: TABLETOP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 227
TABLE 246 MIDDLE EAST & AFRICA: TABLETOP OXIMETERS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 228
TABLE 247 LIST OF JOURNALS THAT ASSESS ROLE OF ACTIGRAPHY SYSTEMS IN SLEEP APNEA 228
TABLE 248 ACTIGRAPHY SYSTEMS MARKET, BY REGION, 2023–2032 (USD MILLION) 229
TABLE 249 NORTH AMERICA: ACTIGRAPHY SYSTEMS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 229
TABLE 250 EUROPE: ACTIGRAPHY SYSTEMS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 230
TABLE 251 ASIA PACIFIC: ACTIGRAPHY SYSTEMS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 230
TABLE 252 LATIN AMERICA: ACTIGRAPHY SYSTEMS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 231
TABLE 253 MIDDLE EAST & AFRICA: ACTIGRAPHY SYSTEMS MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 231
TABLE 254 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS 232
TABLE 255 SLEEP SCREENING DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 232
TABLE 256 NORTH AMERICA: SLEEP SCREENING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 233
TABLE 257 EUROPE: SLEEP SCREENING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 233
TABLE 258 ASIA PACIFIC: SLEEP SCREENING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 234
TABLE 259 LATIN AMERICA: SLEEP SCREENING DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 234
TABLE 260 MIDDLE EAST & AFRICA: SLEEP SCREENING DEVICES MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 235
TABLE 261 PREVALENCE OF SLEEP APNEA, BY AGE GROUP, 2024 237
TABLE 262 SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2023–2032 (USD MILLION) 237
TABLE 263 SLEEP APNEA DEVICES MARKET FOR PEDIATRIC, BY REGION,
2023–2032 (USD MILLION) 238
TABLE 264 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR PEDIATRIC, BY COUNTRY, 2023–2032 (USD MILLION) 238
TABLE 265 EUROPE: SLEEP APNEA DEVICES MARKET FOR PEDIATRIC, BY COUNTRY,
2023–2032 (USD MILLION) 239
TABLE 266 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR PEDIATRIC, BY COUNTRY, 2023–2032 (USD MILLION) 239
TABLE 267 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR PEDIATRIC, BY COUNTRY, 2023–2032 (USD MILLION) 240
TABLE 268 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR PEDIATRIC,
BY COUNTRY, 2023–2032 (USD MILLION) 240
TABLE 269 SLEEP APNEA DEVICES MARKET FOR BELOW 40 YEARS, BY REGION,
2023–2032 (USD MILLION) 241
TABLE 270 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR BELOW 40 YEARS,
BY COUNTRY, 2023–2032 (USD MILLION) 241
TABLE 271 EUROPE: SLEEP APNEA DEVICES MARKET FOR BELOW 40 YEARS, BY COUNTRY, 2023–2032 (USD MILLION) 242
TABLE 272 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR BELOW 40 YEARS,
BY COUNTRY, 2023–2032 (USD MILLION) 242
TABLE 273 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR BELOW 40 YEARS,
BY COUNTRY, 2023–2032 (USD MILLION) 243
TABLE 274 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR BELOW 40 YEARS, BY COUNTRY, 2023–2032 (USD MILLION) 243
TABLE 275 SLEEP APNEA DEVICES MARKET FOR 40–60 YEARS, BY REGION,
2023–2032 (USD MILLION) 244
TABLE 276 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR 40–60 YEARS,
BY COUNTRY, 2023–2032 (USD MILLION) 245
TABLE 277 EUROPE: SLEEP APNEA DEVICES MARKET FOR 40–60 YEARS, BY COUNTRY, 2023–2032 (USD MILLION) 245
TABLE 278 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR 40–60 YEARS, BY COUNTRY, 2023–2032 (USD MILLION) 246
TABLE 279 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR 40–60 YEARS, BY COUNTRY, 2023–2032 (USD MILLION) 246
TABLE 280 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR 40–60 YEARS,
BY COUNTRY, 2023–2032 (USD MILLION) 247
TABLE 281 SLEEP APNEA DEVICES MARKET FOR ABOVE 60 YEARS, BY REGION,
2023–2032 (USD MILLION) 248
TABLE 282 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR ABOVE 60 YEARS,
BY COUNTRY, 2023–2032 (USD MILLION) 248
TABLE 283 EUROPE: SLEEP APNEA DEVICES MARKET FOR ABOVE 60 YEARS, BY COUNTRY, 2023–2032 (USD MILLION) 249
TABLE 284 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR ABOVE 60 YEARS,
BY COUNTRY, 2023–2032 (USD MILLION) 249
TABLE 285 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR ABOVE 60 YEARS,
BY COUNTRY, 2023–2032 (USD MILLION) 250
TABLE 286 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR ABOVE 60 YEARS, BY COUNTRY, 2023–2032 (USD MILLION) 250
TABLE 287 SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 252
TABLE 288 PREVALENCE OF SLEEP APNEA, BY AGE GROUP AND GENDER 252
TABLE 289 SLEEP APNEA DEVICES MARKET FOR MALE PATIENTS, BY REGION,
2023–2032 (USD MILLION) 253
TABLE 290 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2023–2032 (USD MILLION) 253
TABLE 291 EUROPE: SLEEP APNEA DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2023–2032 (USD MILLION) 254
TABLE 292 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2023–2032 (USD MILLION) 254
TABLE 293 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2023–2032 (USD MILLION) 255
TABLE 294 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2023–2032 (USD MILLION) 255
TABLE 295 SLEEP APNEA DEVICES MARKET FOR FEMALE PATIENTS, BY REGION,
2023–2032 (USD MILLION) 256
TABLE 296 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR FEMALE PATIENTS,
BY COUNTRY, 2023–2032 (USD MILLION) 256
TABLE 297 EUROPE: SLEEP APNEA DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2023–2032 (USD MILLION) 257
TABLE 298 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR FEMALE PATIENTS,
BY COUNTRY, 2023–2032 (USD MILLION) 257
TABLE 299 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR FEMALE PATIENTS,
BY COUNTRY, 2023–2032 (USD MILLION) 258
TABLE 300 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2023–2032 (USD MILLION) 258
TABLE 301 SLEEP APNEA DEVICES MARKET, BY END USER, 2023–2032 (USD MILLION) 260
TABLE 302 SLEEP APNEA DEVICES MARKET FOR HOSPITALS, BY REGION,
2023–2032 (USD MILLION) 261
TABLE 303 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2032 (USD MILLION) 261
TABLE 304 EUROPE: SLEEP APNEA DEVICES MARKET FOR HOSPITALS, BY COUNTRY,
2023–2032 (USD MILLION) 262
TABLE 305 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2032 (USD MILLION) 262
TABLE 306 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2032 (USD MILLION) 263
TABLE 307 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR HOSPITALS,
BY COUNTRY, 2023–2032 (USD MILLION) 263
TABLE 308 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION,
2023–2032 (USD MILLION) 265
TABLE 309 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2023–2032 (USD MILLION) 265
TABLE 310 EUROPE: SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2023–2032 (USD MILLION) 266
TABLE 311 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2023–2032 (USD MILLION) 266
TABLE 312 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2023–2032 (USD MILLION) 267
TABLE 313 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2032 (USD MILLION) 267
TABLE 314 SLEEP APNEA DEVICES MARKET FOR SLEEP CLINICS, BY REGION,
2023–2032 (USD MILLION) 269
TABLE 315 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR SLEEP CLINICS,
BY COUNTRY, 2023–2032 (USD MILLION) 269
TABLE 316 EUROPE: SLEEP APNEA DEVICES MARKET FOR SLEEP CLINICS, BY COUNTRY, 2023–2032 (USD MILLION) 270
TABLE 317 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR SLEEP CLINICS, BY COUNTRY, 2023–2032 (USD MILLION) 270
TABLE 318 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR SLEEP CLINICS,
BY COUNTRY, 2023–2032 (USD MILLION) 271
TABLE 319 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR SLEEP CLINICS,
BY COUNTRY, 2023–2032 (USD MILLION) 271
TABLE 320 SLEEP APNEA DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023–2032 (USD MILLION) 273
TABLE 321 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2023–2032 (USD MILLION) 273
TABLE 322 EUROPE: SLEEP APNEA DEVICES MARKET FOR AMBULATORY CARE CENTERS,
BY COUNTRY, 2023–2032 (USD MILLION) 274
TABLE 323 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2023–2032 (USD MILLION) 274
TABLE 324 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2023–2032 (USD MILLION) 275
TABLE 325 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2023–2032 (USD MILLION) 275
TABLE 326 SLEEP APNEA DEVICES MARKET FOR PRIMARY CENTERS, BY REGION,
2023–2032 (USD MILLION) 276
TABLE 327 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR PRIMARY CENTERS,
BY COUNTRY, 2023–2032 (USD MILLION) 277
TABLE 328 EUROPE: SLEEP APNEA DEVICES MARKET FOR PRIMARY CENTERS, BY COUNTRY, 2023–2032 (USD MILLION) 277
TABLE 329 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR PRIMARY CENTERS,
BY COUNTRY, 2023–2032 (USD MILLION) 278
TABLE 330 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR PRIMARY CENTERS,
BY COUNTRY, 2023–2032 (USD MILLION) 278
TABLE 331 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR PRIMARY CENTERS, BY COUNTRY, 2023–2032 (USD MILLION) 279
TABLE 332 SLEEP APNEA DEVICES MARKET FOR OTHER END USERS, BY REGION,
2023–2032 (USD MILLION) 280
TABLE 333 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2032 (USD MILLION) 280
TABLE 334 EUROPE: SLEEP APNEA DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2032 (USD MILLION) 281
TABLE 335 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2032 (USD MILLION) 281
TABLE 336 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2032 (USD MILLION) 282
TABLE 337 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2032 (USD MILLION) 282
TABLE 338 SLEEP APNEA DEVICES MARKET, BY REGION, 2023–2032 (USD MILLION) 284
TABLE 339 NORTH AMERICA: KEY MACROINDICATORS 285
TABLE 340 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 286
TABLE 341 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (THOUSAND UNITS) 286
TABLE 342 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 286
TABLE 343 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 287
TABLE 344 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 287
TABLE 345 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 287
TABLE 346 NORTH AMERICA: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 288
TABLE 347 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 288
TABLE 348 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE,
2023–2032 (USD MILLION) 289
TABLE 349 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 289
TABLE 350 NORTH AMERICA: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 290
TABLE 351 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 290
TABLE 352 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 290
TABLE 353 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 291
TABLE 354 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 291
TABLE 355 US: SLEEP APNEA PRODUCTS OFFERED BY KEY PLAYERS 293
TABLE 356 US: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 294
TABLE 357 US: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 294
TABLE 358 US: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 294
TABLE 359 US: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 295
TABLE 360 US: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 295
TABLE 361 US: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 295
TABLE 362 US: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 296
TABLE 363 US: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 296
TABLE 364 US: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 296
TABLE 365 US: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 297
TABLE 366 US: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2023–2032 (USD MILLION) 297
TABLE 367 US: SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 297
TABLE 368 US: SLEEP APNEA DEVICES MARKET, BY END USER, 2023–2032 (USD MILLION) 298
TABLE 369 CANADA: SLEEP APNEA PRODUCTS OFFERED BY KEY PLAYERS 299
TABLE 370 CANADA: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 300
TABLE 371 CANADA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 300
TABLE 372 CANADA: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 300
TABLE 373 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 301
TABLE 374 CANADA: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 301
TABLE 375 CANADA: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 301
TABLE 376 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 302
TABLE 377 CANADA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 302
TABLE 378 CANADA: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 303
TABLE 379 CANADA: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 303
TABLE 380 CANADA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 303
TABLE 381 CANADA: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 304
TABLE 382 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 304
TABLE 383 EUROPE: KEY MACROINDICATORS 305
TABLE 384 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 306
TABLE 385 EUROPE: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 306
TABLE 386 EUROPE: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (THOUSAND UNITS) 306
TABLE 387 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 307
TABLE 388 EUROPE: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 307
TABLE 389 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 307
TABLE 390 EUROPE: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 308
TABLE 391 EUROPE: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 308
TABLE 392 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 309
TABLE 393 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 309
TABLE 394 EUROPE: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 309
TABLE 395 EUROPE: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 310
TABLE 396 EUROPE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 310
TABLE 397 EUROPE: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 310
TABLE 398 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 311
TABLE 399 GERMANY: SLEEP APNEA PRODUCTS BY MAJOR PLAYERS 312
TABLE 400 GERMANY: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 312
TABLE 401 GERMANY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 313
TABLE 402 GERMANY: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 313
TABLE 403 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 313
TABLE 404 GERMANY: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 314
TABLE 405 GERMANY: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 314
TABLE 406 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 315
TABLE 407 GERMANY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 315
TABLE 408 GERMANY: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 316
TABLE 409 GERMANY: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 316
TABLE 410 GERMANY: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 316
TABLE 411 GERMANY: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 317
TABLE 412 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 317
TABLE 413 UK: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 318
TABLE 414 UK: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 319
TABLE 415 UK: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 319
TABLE 416 UK: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 319
TABLE 417 UK: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 320
TABLE 418 UK: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 320
TABLE 419 UK: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 321
TABLE 420 UK: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 321
TABLE 421 UK: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 321
TABLE 422 UK: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 322
TABLE 423 UK: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2023–2032 (USD MILLION) 322
TABLE 424 UK: SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 322
TABLE 425 UK: SLEEP APNEA DEVICES MARKET, BY END USER, 2023–2032 (USD MILLION) 323
TABLE 426 FRANCE: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 324
TABLE 427 FRANCE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 324
TABLE 428 FRANCE: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 324
TABLE 429 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 325
TABLE 430 FRANCE: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 325
TABLE 431 FRANCE: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 325
TABLE 432 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 326
TABLE 433 FRANCE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 326
TABLE 434 FRANCE: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 326
TABLE 435 FRANCE: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 327
TABLE 436 FRANCE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 327
TABLE 437 FRANCE: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 327
TABLE 438 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 328
TABLE 439 ITALY: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 329
TABLE 440 ITALY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 329
TABLE 441 ITALY: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 329
TABLE 442 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 330
TABLE 443 ITALY: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 330
TABLE 444 ITALY: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 330
TABLE 445 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 331
TABLE 446 ITALY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 331
TABLE 447 ITALY: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 331
TABLE 448 ITALY: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 332
TABLE 449 ITALY: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 332
TABLE 450 ITALY: SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 332
TABLE 451 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER, 2023–2032 (USD MILLION) 333
TABLE 452 SPAIN: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 334
TABLE 453 SPAIN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 334
TABLE 454 SPAIN: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 334
TABLE 455 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 335
TABLE 456 SPAIN: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 335
TABLE 457 SPAIN: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 335
TABLE 458 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 336
TABLE 459 SPAIN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 336
TABLE 460 SPAIN: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 336
TABLE 461 SPAIN: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 337
TABLE 462 SPAIN: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 337
TABLE 463 SPAIN: SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 337
TABLE 464 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 338
TABLE 465 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 339
TABLE 466 REST OF EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 339
TABLE 467 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 340
TABLE 468 REST OF EUROPE: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 340
TABLE 469 REST OF EUROPE: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 340
TABLE 470 REST OF EUROPE: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 341
TABLE 471 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE,
2023–2032 (USD MILLION) 341
TABLE 472 REST OF EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 342
TABLE 473 REST OF EUROPE: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 342
TABLE 474 REST OF EUROPE: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 343
TABLE 475 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 343
TABLE 476 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 344
TABLE 477 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 344
TABLE 478 ASIA PACIFIC: KEY MARCOINDICATORS 345
TABLE 479 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 347
TABLE 480 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (THOUSAND UNITS) 347
TABLE 481 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 347
TABLE 482 ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 348
TABLE 483 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 348
TABLE 484 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 348
TABLE 485 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 349
TABLE 486 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 349
TABLE 487 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 350
TABLE 488 ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 350
TABLE 489 ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 350
TABLE 490 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 351
TABLE 491 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 351
TABLE 492 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 351
TABLE 493 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 352
TABLE 494 CHINA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 353
TABLE 495 CHINA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 353
TABLE 496 CHINA: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 353
TABLE 497 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 354
TABLE 498 CHINA: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 354
TABLE 499 CHINA: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 354
TABLE 500 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 355
TABLE 501 CHINA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 355
TABLE 502 CHINA: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 355
TABLE 503 CHINA: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 356
TABLE 504 CHINA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 356
TABLE 505 CHINA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 356
TABLE 506 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 357
TABLE 507 JAPAN: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 358
TABLE 508 JAPAN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 358
TABLE 509 JAPAN: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 358
TABLE 510 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 359
TABLE 511 JAPAN: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 359
TABLE 512 JAPAN: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 359
TABLE 513 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 360
TABLE 514 JAPAN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 360
TABLE 515 JAPAN: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 360
TABLE 516 JAPAN: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 361
TABLE 517 JAPAN: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 361
TABLE 518 JAPAN: SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 361
TABLE 519 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 362
TABLE 520 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 363
TABLE 521 AUSTRALIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 363
TABLE 522 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 363
TABLE 523 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 364
TABLE 524 AUSTRALIA: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 364
TABLE 525 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 364
TABLE 526 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 365
TABLE 527 AUSTRALIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 365
TABLE 528 AUSTRALIA: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 365
TABLE 529 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 366
TABLE 530 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 366
TABLE 531 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 366
TABLE 532 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 367
TABLE 533 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 368
TABLE 534 REST OF ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 368
TABLE 535 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 369
TABLE 536 REST OF ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 369
TABLE 537 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 369
TABLE 538 REST OF ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE,
2023–2032 (USD MILLION) 370
TABLE 539 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE,
2023–2032 (USD MILLION) 370
TABLE 540 REST OF ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 371
TABLE 541 REST OF ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 371
TABLE 542 REST OF ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 372
TABLE 543 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 372
TABLE 544 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 373
TABLE 545 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 373
TABLE 546 LATIN AMERICA: KEY MARCOINDICATORS 374
TABLE 547 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 375
TABLE 548 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 375
TABLE 549 LATIN AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 376
TABLE 550 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 376
TABLE 551 LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 376
TABLE 552 LATIN AMERICA: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 377
TABLE 553 LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 377
TABLE 554 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 378
TABLE 555 LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 378
TABLE 556 LATIN AMERICA: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 379
TABLE 557 LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 379
TABLE 558 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 379
TABLE 559 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 380
TABLE 560 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 380
TABLE 561 BRAZIL: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 381
TABLE 562 BRAZIL: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 382
TABLE 563 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 382
TABLE 564 BRAZIL: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 382
TABLE 565 BRAZIL: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 383
TABLE 566 BRAZIL: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 383
TABLE 567 BRAZIL: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 384
TABLE 568 BRAZIL: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 384
TABLE 569 BRAZIL: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 384
TABLE 570 BRAZIL: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 385
TABLE 571 BRAZIL: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 385
TABLE 572 BRAZIL: SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 385
TABLE 573 BRAZIL: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 386
TABLE 574 MEXICO: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 387
TABLE 575 MEXICO: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 387
TABLE 576 MEXICO: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 387
TABLE 577 MEXICO: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 388
TABLE 578 MEXICO: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 388
TABLE 579 MEXICO: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 388
TABLE 580 MEXICO: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 389
TABLE 581 MEXICO: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 389
TABLE 582 MEXICO: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 390
TABLE 583 MEXICO: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 390
TABLE 584 MEXICO: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 390
TABLE 585 MEXICO: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 391
TABLE 586 MEXICO: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 391
TABLE 587 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 392
TABLE 588 REST OF LATIN AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 392
TABLE 589 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 393
TABLE 590 REST OF LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 393
TABLE 591 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 393
TABLE 592 REST OF LATIN AMERICA: ACCESSORIES MARKET, BY TYPE,
2023–2032 (USD MILLION) 394
TABLE 593 REST OF LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE,
2023–2032 (USD MILLION) 394
TABLE 594 REST OF LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 395
TABLE 595 REST OF LATIN AMERICA: PSG DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 395
TABLE 596 REST OF LATIN AMERICA: OXIMETERS MARKET, BY TYPE,
2023–2032 (USD MILLION) 396
TABLE 597 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 396
TABLE 598 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 397
TABLE 599 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 397
TABLE 600 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 398
TABLE 601 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY REGION,
2023–2032 (USD MILLION) 399
TABLE 602 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 399
TABLE 603 MIDDLE EAST & AFRICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 400
TABLE 604 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 400
TABLE 605 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 401
TABLE 606 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 401
TABLE 607 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE,
2023–2032 (USD MILLION) 402
TABLE 608 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE,
2023–2032 (USD MILLION) 402
TABLE 609 MIDDLE EAST & AFRICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 403
TABLE 610 MIDDLE EAST & AFRICA: PSG DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 403
TABLE 611 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE,
2023–2032 (USD MILLION) 404
TABLE 612 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 404
TABLE 613 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 405
TABLE 614 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 405
TABLE 615 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 406
TABLE 616 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 406
TABLE 617 GCC COUNTRIES: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 407
TABLE 618 GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 407
TABLE 619 GCC COUNTRIES: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 407
TABLE 620 GCC COUNTRIES: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 408
TABLE 621 GCC COUNTRIES: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 408
TABLE 622 GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE,
2023–2032 (USD MILLION) 409
TABLE 623 GCC COUNTRIES: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 409
TABLE 624 GCC COUNTRIES: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 410
TABLE 625 GCC COUNTRIES: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 410
TABLE 626 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,
2023–2032 (USD MILLION) 410
TABLE 627 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 411
TABLE 628 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 411
TABLE 629 KINGDOM OF SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 412
TABLE 630 KINGDOM OF SAUDI ARABIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET,
BY TYPE, 2023–2032 (USD MILLION) 413
TABLE 631 KINGDOM OF SAUDI ARABIA: PAP DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 413
TABLE 632 KINGDOM OF SAUDI ARABIA: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 414
TABLE 633 KINGDOM OF SAUDI ARABIA: MASKS MARKET, BY TYPE,
2023–2032 (USD MILLION) 414
TABLE 634 KINGDOM OF SAUDI ARABIA: ACCESSORIES MARKET, BY TYPE,
2023–2032 (USD MILLION) 415
TABLE 635 KINGDOM OF SAUDI ARABIA: ORAL APPLIANCES MARKET, BY TYPE,
2023–2032 (USD MILLION) 415
TABLE 636 KINGDOM OF SAUDI ARABIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET,
BY TYPE, 2023–2032 (USD MILLION) 416
TABLE 637 KINGDOM OF SAUDI ARABIA: PSG DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 416
TABLE 638 KINGDOM OF SAUDI ARABIA: OXIMETERS MARKET, BY TYPE,
2023–2032 (USD MILLION) 417
TABLE 639 KINGDOM OF SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2023–2032 (USD MILLION) 417
TABLE 640 KINGDOM OF SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 418
TABLE 641 KINGDOM OF SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2023–2032 (USD MILLION) 418
TABLE 642 UAE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 419
TABLE 643 UAE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 419
TABLE 644 UAE: PAP DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 420
TABLE 645 UAE: FACIAL INTERFACES MARKET, BY TYPE, 2023–2032 (USD MILLION) 420
TABLE 646 UAE: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 420
TABLE 647 UAE: ACCESSORIES MARKET, BY TYPE, 2023–2032 (USD MILLION) 421
TABLE 648 UAE: ORAL APPLIANCES MARKET, BY TYPE, 2023–2032 (USD MILLION) 421
TABLE 649 UAE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 422
TABLE 650 UAE: PSG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 422
TABLE 651 UAE: OXIMETERS MARKET, BY TYPE, 2023–2032 (USD MILLION) 423
TABLE 652 UAE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2023–2032 (USD MILLION) 423
TABLE 653 UAE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 423
TABLE 654 UAE: SLEEP APNEA DEVICES MARKET, BY END USER, 2023–2032 (USD MILLION) 424
TABLE 655 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 424
TABLE 656 REST OF GCC COUNTRIES: SLEEP APNEA THERAPEUTIC DEVICES MARKET,
BY TYPE, 2023–2032 (USD MILLION) 425
TABLE 657 REST OF GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 425
TABLE 658 REST OF GCC COUNTRIES: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 426
TABLE 659 REST OF GCC COUNTRIES: MASKS MARKET, BY TYPE, 2023–2032 (USD MILLION) 426
TABLE 660 REST OF GCC COUNTRIES: ACCESSORIES MARKET, BY TYPE,
2023–2032 (USD MILLION) 427
TABLE 661 REST OF GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE,
2023–2032 (USD MILLION) 427
TABLE 662 REST OF GCC COUNTRIES: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 428
TABLE 663 REST OF GCC COUNTRIES: PSG DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 428
TABLE 664 REST OF GCC COUNTRIES: OXIMETERS MARKET, BY TYPE,
2023–2032 (USD MILLION) 429
TABLE 665 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2023–2032 (USD MILLION) 429
TABLE 666 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY GENDER,
2023–2032 (USD MILLION) 430
TABLE 667 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY END USER,
2023–2032 (USD MILLION) 430
TABLE 668 REST OF MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 431
TABLE 669 REST OF MIDDLE EAST & AFRICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 432
TABLE 670 REST OF MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 432
TABLE 671 REST OF MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE,
2023–2032 (USD MILLION) 433
TABLE 672 REST OF MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE,
2023–2032 (USD MILLION) 433
TABLE 673 REST OF MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE,
2023–2032 (USD MILLION) 434
TABLE 674 REST OF MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE,
2023–2032 (USD MILLION) 434
TABLE 675 REST OF MIDDLE EAST & AFRICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET,
BY TYPE, 2023–2032 (USD MILLION) 435
TABLE 676 REST OF MIDDLE EAST & AFRICA: PSG DEVICES MARKET, BY TYPE,
2023–2032 (USD MILLION) 435
TABLE 677 REST OF MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE,
2023–2032 (USD MILLION) 436
TABLE 678 REST OF MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET,
BY AGE GROUP, 2023–2032 (USD MILLION) 436
TABLE 679 REST OF MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2023–2032 (USD MILLION) 437
TABLE 680 REST OF MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2023–2032 (USD MILLION) 437
TABLE 681 OVERVIEW OF STRATEGIES ADOPTED BY KEY SLEEP APNEA DEVICE MANUFACTURING COMPANIES 438
TABLE 682 SLEEP APNEA DEVICES MARKET: DEGREE OF COMPETITION 441
TABLE 683 SLEEP APNEA DEVICES MARKET: REGION FOOTPRINT 444
TABLE 684 SLEEP APNEA DEVICES MARKET: PRODUCT FOOTPRINT 445
TABLE 685 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 447
TABLE 686 SLEEP APNEA DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS 448
TABLE 687 SLEEP APNEA DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2025 450
TABLE 688 SLEEP APNEA DEVICES MARKET: DEALS, JANUARY 2022–JUNE 2025 451
TABLE 689 SLEEP APNEA DEVICES MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 452
TABLE 690 SLEEP APNEA DEVICES MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–JUNE 2025 452
TABLE 691 RESMED: COMPANY OVERVIEW 453
TABLE 692 RESMED: PRODUCTS OFFERED 454
TABLE 693 RESMED: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 457
TABLE 694 RESMED: DEALS, JANUARY 2022–JUNE 2025 457
TABLE 695 RESMED: EXPANSIONS, JANUARY 2022–JUNE 2025 458
TABLE 696 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 459
TABLE 697 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 460
TABLE 698 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW 464
TABLE 699 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCTS OFFERED 465
TABLE 700 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES,
JANUARY 2022–JUNE 2025 467
TABLE 701 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 469
TABLE 702 INSPIRE MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED 470
TABLE 703 SOMNOMED: COMPANY OVERVIEW 471
TABLE 704 SOMNOMED: PRODUCTS OFFERED 472
TABLE 705 OPENAIRWAY: COMPANY OVERVIEW 473
TABLE 706 OPENAIRWAY: PRODUCTS OFFERED 473
TABLE 707 COMPUMEDICS LIMITED: COMPANY OVERVIEW 474
TABLE 708 COMPUMEDICS LIMITED: PRODUCTS OFFERED 475
TABLE 709 COMPUMEDICS LIMITED: PRODUCT APPROVALS, JANUARY 2022–JUNE 2025 476
TABLE 710 LÖWENSTEIN MEDICAL SE & CO. KG: COMPANY OVERVIEW 477
TABLE 711 LÖWENSTEIN MEDICAL SE & CO. KG: PRODUCTS OFFERED 477
TABLE 712 DRIVE DEVILBISS INTERNATIONAL: COMPANY OVERVIEW 479
TABLE 713 DRIVE DEVILBISS INTERNATIONAL: PRODUCTS OFFERED 479
TABLE 714 BMC: COMPANY OVERVIEW 480
TABLE 715 BMC: PRODUCTS OFFERED 480
TABLE 716 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW 482
TABLE 717 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED 482
TABLE 718 DYNAFLEX: COMPANY OVERVIEW 483
TABLE 719 DYNAFLEX: PRODUCTS OFFERED 483
TABLE 720 DYNAFLEX: DEALS, JANUARY 2022–JUNE 2025 483
TABLE 721 PANTHERA DENTAL: COMPANY OVERVIEW 484
TABLE 722 PANTHERA DENTAL: PRODUCTS OFFERED 484
TABLE 723 PANTHERA DENTAL: DEALS, JANUARY 2022–JUNE 2025 484
TABLE 724 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 485
TABLE 725 MYERSON LLC: COMPANY OVERVIEW 486
TABLE 726 MYERSON LLC: PRODUCTS OFFERED 486
TABLE 727 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW 487
TABLE 728 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED 488
TABLE 729 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2022–JUNE 2025 488
TABLE 730 NIDEK MEDICAL INDIA: COMPANY OVERVIEW 489
TABLE 731 TOMED GMBH: COMPANY OVERVIEW 489
TABLE 732 LIVANOVA PLC: COMPANY OVERVIEW 490
TABLE 733 INVACARE HOLDINGS CORPORATION: COMPANY OVERVIEW 490
TABLE 734 MPOWRX HEALTH & WELLNESS PRODUCTS INC.: COMPANY OVERVIEW 491
TABLE 735 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 492
TABLE 736 SICAT GMBH & CO. KG: COMPANY OVERVIEW 493
TABLE 737 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW 494
TABLE 738 AIRWAY MANAGEMENT: COMPANY OVERVIEW 495
TABLE 739 APNEA SCIENCES: COMPANY OVERVIEW 496
LIST OF FIGURES
FIGURE 1 SLEEP APNEA DEVICES MARKET SEGMENTATION & REGIONAL SCOPE 46
FIGURE 2 SLEEP APNEA DEVICES MARKET: YEARS CONSIDERED 47
FIGURE 3 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN 50
FIGURE 4 SLEEP APNEA DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES 52
FIGURE 5 SLEEP APNEA DEVICES MARKET: LIST OF KEY PRIMARIES
(DEMAND AND SUPPLY SIDES) 53
FIGURE 6 SLEEP APNEA DEVICES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 54
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 55
FIGURE 8 SLEEP APNEA DEVICES MARKET: COMPANY REVENUE ESTIMATION APPROACH 57
FIGURE 9 SLEEP APNEA DEVICES MARKET: PATIENT-BASED ANALYSIS FOR
SLEEP APNEA ORAL APPLIANCES 58
FIGURE 10 SLEEP APNEA DEVICES MARKET: CAGR PROJECTIONS (SUPPLY SIDE) 59
FIGURE 11 SLEEP APNEA DEVICES MARKET: TOP-DOWN APPROACH 60
FIGURE 12 SLEEP APNEA DEVICES MARKET: DATA TRIANGULATION 61
FIGURE 13 SLEEP APNEA DEVICES MARKET: MARKET ASSUMPTIONS 62
FIGURE 14 SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2025 VS. 2032 (USD MILLION) 64
FIGURE 15 SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2025 VS. 2032 (USD MILLION) 65
FIGURE 16 SLEEP APNEA DEVICES MARKET, BY GENDER, 2025 VS. 2032 (USD MILLION) 65
FIGURE 17 SLEEP APNEA DEVICES MARKET, BY END USER, 2025 VS. 2032 (USD MILLION) 66
FIGURE 18 SLEEP APNEA DEVICES MARKET, BY REGION, 2025 VS. 2032 (USD MILLION) 66
FIGURE 19 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE MARKET 68
FIGURE 20 THERAPEUTIC DEVICES TO REGISTER HIGHEST GROWTH RATE TILL 2032 69
FIGURE 21 US AND THERAPEUTIC DEVICES DOMINATED NORTH AMERICAN
SLEEP APNEA DEVICES MARKET IN 2024 69
FIGURE 22 NORTH AMERICA COMMANDED LARGEST SLEEP APNEA DEVICES
MARKET SHARE IN 2024 70
FIGURE 23 SLEEP APNEA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 71
FIGURE 24 SLEEP APNEA DEVICES MARKET: VALUE CHAIN ANALYSIS 86
FIGURE 25 SLEEP APNEA DEVICES MARKET: SUPPLY CHAIN ANALYSIS 87
FIGURE 26 SLEEP APNEA DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 89
FIGURE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER 91
FIGURE 28 KEY BUYING CRITERIA FOR MAJOR END USERS 92
FIGURE 29 SLEEP APNEA DEVICES MARKET: ECOSYSTEM ANALYSIS 93
FIGURE 30 TOP 10 COMPANIES WITH HIGHEST NUMBER OF PATENT APPLICATIONS/OWNERSHIPS, 2015–2024 102
FIGURE 31 ADJACENT MARKETS FOR SLEEP APNEA DEVICES MARKET 103
FIGURE 32 SLEEP APNEA DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING
CUSTOMERS’ BUSINESSES 104
FIGURE 33 SLEEP APNEA DEVICES MARKET: FUNDING AND NUMBER OF DEALS, 2019−2024 109
FIGURE 34 MARKET POTENTIAL OF AI/GEN AI IN SLEEP APNEA DEVICES MARKET 111
FIGURE 35 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT 285
FIGURE 36 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT 346
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA DEVICES MARKET, 2020−2024 (USD MILLION) 440
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA DEVICES MARKET (2024) 441
FIGURE 39 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 443
FIGURE 40 SLEEP APNEA DEVICES MARKET: COMPANY FOOTPRINT 444
FIGURE 41 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 447
FIGURE 42 EV/EBITDA OF KEY VENDORS 449
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 449
FIGURE 44 SLEEP APNEA DEVICES MARKET: BRAND/PRODUCT COMPARATIVE
ANALYSIS FOR CPAP DEVICES 450
FIGURE 45 RESMED: COMPANY SNAPSHOT 454
FIGURE 46 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 460
FIGURE 47 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT 465
FIGURE 48 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 469
FIGURE 49 SOMNOMED: COMPANY SNAPSHOT 471
FIGURE 50 COMPUMEDICS LIMITED: COMPANY SNAPSHOT 475
FIGURE 51 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT 487
MarketsandMarkets(マーケッツアンドマーケッツ)は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間~12時間以内(営業日基準)にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連会社除く)5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100%持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内(営業日基準)
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11